Literature DB >> 21346785

The integrin signalling adaptor p130CAS is also a key player in prostate cancer.

Gaelle Fromont, Olivier Cussenot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21346785     DOI： 10.1038/nrc2967-c1

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  6 in total

1.  BCAR1 expression in prostate cancer: association with 16q23 LOH status, tumor progression and EGFR/KAI1 staining.

Authors:  Gaëlle Fromont; Guy Vallancien; Pierre Validire; Pierre Levillain; Olivier Cussenot
Journal:  Prostate       Date:  2007-02-15       Impact factor: 4.104

2.  Expression of estrogen related proteins in hormone refractory prostate cancer: association with tumor progression.

Authors:  Olivier Celhay; Mokrane Yacoub; Jacques Irani; Bertrand Dore; Olivier Cussenot; Gaelle Fromont
Journal:  J Urol       Date:  2010-09-17       Impact factor: 7.450

Review 3.  Integrin signalling adaptors: not only figurants in the cancer story.

Authors:  Sara Cabodi; Maria del Pilar Camacho-Leal; Paola Di Stefano; Paola Defilippi
Journal:  Nat Rev Cancer       Date:  2010-11-24       Impact factor: 60.716

4.  Requirement of the p130CAS-Crk coupling for metastasis suppressor KAI1/CD82-mediated inhibition of cell migration.

Authors:  Xin A Zhang; Bo He; Bin Zhou; Li Liu
Journal:  J Biol Chem       Date:  2003-05-08       Impact factor: 5.157

5.  Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530.

Authors:  Y-M Chang; L Bai; S Liu; J C Yang; H-J Kung; C P Evans
Journal:  Oncogene       Date:  2008-08-04       Impact factor: 9.867

6.  Homozygous deletions and recurrent amplifications implicate new genes involved in prostate cancer.

Authors:  Wennuan Liu; Chunmei Carol Xie; Yi Zhu; Tao Li; Jishan Sun; Yu Cheng; Charles M Ewing; Sue Dalrymple; Aubrey R Turner; Jielin Sun; John T Isaacs; Bao-Li Chang; Siqun Lilly Zheng; William B Isaacs; Jianfeng Xu
Journal:  Neoplasia       Date:  2008-08       Impact factor: 5.715
  6 in total
  6 in total

1.  Regulation of p130(Cas)/BCAR1 expression in tamoxifen-sensitive and tamoxifen-resistant breast cancer cells by EGR1 and NAB2.

Authors:  Joerg Kumbrink; Kathrin H Kirsch
Journal:  Neoplasia       Date:  2012-02       Impact factor: 5.715

2.  NSP-CAS Protein Complexes: Emerging Signaling Modules in Cancer.

Authors:  Yann Wallez; Peter D Mace; Elena B Pasquale; Stefan J Riedl
Journal:  Genes Cancer       Date:  2012-05

3.  LPA Stimulates the Phosphorylation of p130Cas via Gαi2 in Ovarian Cancer Cells.

Authors:  Jeremy D Ward; Danny N Dhanasekaran
Journal:  Genes Cancer       Date:  2012-09

4.  Integrin α5 promotes migration and invasion through the FAK/STAT3/AKT signaling pathway in icotinib-resistant non-small cell lung cancer cells.

Authors:  Yang Yang; Yizhe Wang; Xiaofang Che; Kezuo Hou; Jie Wu; Chunlei Zheng; Yang Cheng; Yunpeng Liu; Xuejun Hu; Jingdong Zhang
Journal:  Oncol Lett       Date:  2021-05-24       Impact factor: 2.967

5.  Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo".

Authors:  Maria Elisa Perico; Silvia Grasso; Matteo Brunelli; Guido Martignoni; Enrico Munari; Enrico Moiso; Giulio Fracasso; Tiziana Cestari; Hassan Y Naim; Vincenzo Bronte; Marco Colombatti; Dunia Ramarli
Journal:  Oncotarget       Date:  2016-11-08

6.  The interaction of p130Cas with PKN3 promotes malignant growth.

Authors:  Jakub Gemperle; Michal Dibus; Lenka Koudelková; Daniel Rosel; Jan Brábek
Journal:  Mol Oncol       Date:  2018-12-03       Impact factor: 6.603
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.